Sustained, Powerful Outcomes In Over 5,000 Resolute Patients

Resolute DES Shows Less Than 1% ST Rate in Over 5000 Patients

No Differences Observed After Adjustment to Comparative Statistics in Post-Hoc Analysis1


RESOLUTE Pooled ARC Definite/Probably ST


 

Stent Thrombosis Rates in All Comer Trials

ARC Definite/Probable ST, 12-Month Data


Results from clinical trials are not directly comparable.
Studies not powered for this low frequency ST event.

 

Pooled RESOLUTE TLF Rate

No Differences Observed After Adjustment to Comparative Statistics in Post-Hoc Analysis1

RESOLUTE Pooled TLF Rate

 

Pooled RESOLUTE TLR Rate

No Differences Observed After Adjustment to Comparative Statistics in Post-Hoc Analysis1

RESOLUTE Pooled TLR Rate

 

Analysis of clinical events from prospective trials of the Resolute zotarolimus-eluting stent.
24-month data presented by Leon M. TCT 2011.
1A post hoc analysis. HR and p-value based on Cox regression model adjusted with propensity score quintiles.
2RESOLUTE, RESOLUTE All Comers, RESOLUTE International, RESOLUTE US, RESOLUTE Japan
3DAPT Compliance at 2 years: R-ZES (35.4%), EES (18.1). Outcomes remain consistent when adjusted for duration of DAPT.
4Some of the baseline variables and DAPT time points were significantly different. Actual rates may differ in a head-to-head comparison.
5Includes dual-vessel patients.
6Some of the baseline variables were significantly different. Actual rates may differ in a head to-head comparison.

 

Strong Performance in Diabetics in the RESOLUTE Clinical Program

Over 64% of RESOLUTE Pooled Diabetic Patients Are From All-Comer Trials

All-Comer Trials

 

Strong Performance in Diabetics: RESOLUTE Pooled Analysis1

Non-Diabetic (N = 4477) vs. Diabetics (N = 1805): Target Lesion Failure

RESOLUTE Pooled Diabetic Analysis TLF: Nondiabetics (N = 4477)


RESOLUTE Pooled Diabetic Analysis TLF: Diabetics (N = 1805)

 

TLF=Target Lesion Failure (cardiac death, TVMI and TLR).

 

Resolute DES Shows Low Rates in Cardiac Death/TV MI

RESOLUTE Pooled Analysis: Non-Diabetics (N = 4477) vs. Diabetics (N = 1805)1

RESOLUTE Pooled Diabetic Analysis CD/TVMI: Nondiabetics (N = 4477)


RESOLUTE Pooled Diabetic Analysis CD/TVMI

 

Resolute DES Shows 4.0% TLR Rate In All Diabetics

RESOLUTE Pooled Analysis: Non-Diabetics (N = 4477) vs. Diabetics (N = 1805)1

RESOLUTE Pooled Diabetic Analysis TLR: Nondiabetics (N=4477)


RESOLUTE Pooled Diabetic Analysis TLR: Diabetics (N = 1805)


1A post-hoc analysis. HR and p-value based on Cox regression model adjusted with propensity score quintiles.
2Includes dual-vessel patients.
3RESOLUTE, RESOLUTE All Comers, RESOLUTE International, RESOLUTE US, RESOLUTE Japan.
4Actual rates may differ in a head-to-head comparison.

 

Clinical Data Overview

RESOLUTE All Comers
24 Month Results Summary

 
 

Email Page

Send a link to this page by email along with your comments.
Please enter the information below.

  1. (required)
  2. (required)
  3. (required)